+65 63464191 info@healthytimes.com.sg
Health Magazine Singapore l Singapore Health Magazine l Healthy Times Magazine
  • Home
  • Health
  • Fitness
  • Beauty
  • Food & Nutrition
  • Green Living
  • Kids & Women
  • Disease and Prevention
  • Well Being
  • Events
  • Bahasa
Select Page

Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets

by | PRNewswire Asia

Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody Findings highlight broad therapeutic applicability across oncology, immune, and metabolic diseases SEOUL, South Korea,...

Beauty and Well-being Businesses Looking to Expand Product Portfolio Will Be Charmed by Thai Beauty Products at COSMEX 2025

by | PRNewswire Asia

BANGKOK, Sept. 22, 2025 /PRNewswire/ — COSMEX 2025, ASEAN’s most comprehensive event on OEM service and manufacturing technology for cosmetic, personal care, and dietary supplement products, packaging, printing, labelling, finished product, and beauty...

Amorepacific Presents AI-based Skin Science Innovations and Findings at IFSCC Congress 2025

by | PRNewswire Asia

Unveiling AI architecture for virtual makeup, skin prediction algorithms, and fresh perspectives to skin aging research SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — At the 35th International Federation of Societies of Cosmetics Chemists (IFSCC) Congress...

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer Screening

by | PRNewswire Asia

GUANG’AN, China, Sept. 22, 2025 /PRNewswire/ — PHASE Scientific International Limited ("PHASE Scientific") today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with...

K-Beauty Lives in 2025: IUNIK's Minimalist Beta-Glucan Breakthrough

by | PRNewswire Asia

SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — Do you ever feel like you’re doing too much for your skin yet still battling dryness? You’re not alone. In 2025, many people are discovering that dryness isn’t a sign you need a skincare...

Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer

by | PRNewswire Asia

HONG KONG, Sept. 22, 2025 /PRNewswire/ — Akeso Inc. (9926.HK) has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), evaluating AK130, a fully independently developed TIGIT/TGF-β bifunctional antibody fusion...
« Older Entries
Next Entries »
  • Beauty
  • Disease and Prevention
  • Events
  • Fitness
  • Food and Nutrition
  • Green Living
  • Health
  • Kids and Women
  • News
  • Well Being

PRNewswire Asia

Sitemap

Links

editor@healthytimes.com.sg

editor@healthytimes.com.sg (Press Release)

Phone:+65 63464191

  • Facebook
© Copyright healthytimes.com.sg